Across TCGA pan-cancer cohorts, OR6D1P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of OR6D1P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where OR6D1P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR6D1P is over-expressed in tumor.

KIRC and PRAD are the cancer types where OR6D1P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR6D1P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	IV	+0.025	.043	6	view →
PRAD	All	All	+0.006	.042	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: OR6D1P RNA expression & survival · all OR6D1P data types